COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE

被引:144
作者
RINNE, UK
机构
关键词
D O I
10.1212/WNL.35.8.1196
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:1196 / 1198
页数:3
相关论文
共 26 条
  • [1] [Anonymous], 1982, MOVEMENT DISORD
  • [2] Barbeau A, 1980, PARKINSONS DISEASE C, P229
  • [3] BROMOCRIPTINE IN PARKINSONISM
    CALNE, DB
    TEYCHENNE, PF
    CLAVERIA, LE
    EASTMAN, R
    GREENACRE, JK
    PETRIE, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5942): : 442 - 444
  • [4] CALNE DB, 1983, LISURIDE OTHER DOPAM, P357
  • [5] Carlsson A, 1983, J Neural Transm Suppl, V19, P153
  • [6] DUVOISIN RC, 1971, MONOAMINES NOYAUX GR, P313
  • [7] ROLE OF BROMOCRIPTINE IN THE TREATMENT OF PARKINSONISM
    FAHN, S
    COTE, LJ
    SNIDER, SR
    BARRETT, RE
    ISGREEN, WP
    [J]. NEUROLOGY, 1979, 29 (08) : 1077 - 1083
  • [8] GRANERUS AK, 1978, ACTA MED SCAND, V203, P75
  • [9] PARKINSONISM - ONSET PROGRESSION AND MORTALITY
    HOEHN, MM
    YAHR, MD
    [J]. NEUROLOGY, 1967, 17 (05) : 427 - &
  • [10] ANALYSIS OF THE CLINICAL PROBLEMS IN PARKINSONISM AND THE COMPLICATIONS OF LONG-TERM LEVODOPA THERAPY
    LESSER, RP
    FAHN, S
    SNIDER, SR
    COTE, LJ
    ISGREEN, WP
    BARRETT, RE
    [J]. NEUROLOGY, 1979, 29 (09) : 1253 - 1260